Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aetna Internal PBM No Longer In Play With CVS Caremark Contract

Executive Summary

Aetna's new 12-year contract to merge some of its internal pharmacy benefit management operations with CVS Caremark appears to take Aetna's in-house PBM out of play as a potential acquisition target

You may also be interested in...



PBM Market Competition Will Remain 'Robust' After CVS-Aetna Merger, House Panel Told

CVS General Counsel Thomas Moriarty maintained merger will not involve consolidation of PBM market share.

Humana Weighing Drug Purchasing Change With PBM “Strategic Review”

The insurer is considering strategic options for its internal PBM, which manages more than 300 million drug claims for more than 9 million individuals, mainly in the Medicare space.

Cigna Retains Formulary Management Control Under Contract With PBM Catamaran

Under the 10-year contract, Catamaran will bring its “leading technology and service platform” to enhance operations of Cigna’s internal PBM. The deal is also expected to bolster Cigna’s drug purchasing power and help lower costs.

Related Content

Topics

UsernamePublicRestriction

Register

PS052466

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel